Among women who are newly diagnosed with breast cancer, magnetic resonance imaging (MRI) of the breast appears helpful in determining surgical treatment, according to a report in the May issue of Archives of Surgery, one of the JAMA/Archives journals.
World-renowned scientists will convene at George Mason University on May 21 and 22 to call for a 10-year intellectual revolution ? the “decade of the mind.”
Children appear to approach adult levels of performance on many basic cognitive and motor skills by age 11 or 12, according to a new study coordinated by the National Institutes of Health (NIH).
A University of Arizona scientist who has specialized in studying how fireflies and other creatures communicate has won a million-dollar grant to conduct a pioneering 5-year study on the roles that attention and memory play when the human brain hears and processes spoken language.
Exposure to trauma may create enough changes in the brain to sensitize people to overreact to an innocuous facial gesture years later, even in people who don?t have a stress-related disorder, says new research.
World-renowned scientists are convening at George Mason University to make the case for a “decade of the mind.” This event will launch what is anticipated to be a $4 billion public research initiative aimed at reaching the next levels of understanding the human brain. This research will have dramatic implications on national health and economy.
Abnormalities in the ligaments found on the outside of the knee (lateral collateral ligament complex or LCLC) are commonly seen on MRI in patients with knee osteoarthrosis (OA), according to a study conducted by researchers from Johns Hopkins Hospital in Baltimore, MD and Thomas Jefferson University Hospital in Philadelphia, PA.
CT and MRI are highly accurate at determining which patients would be optimal candidates for liver transplantation, says a recent study.
Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced that data from a 36-week, randomized, doubleblind, placebo-controlled Phase IIb study demonstrated that an oral 0.6 mg dose of laquinimod given daily significantly reduced magnetic resonance imaging (MRI) disease activity by 38 percent in RRMS patients and was well tolerated.
Bayer HealthCare Pharmaceuticals announced the results of three clinical studies with Betaseron? (interferon beta-1b), presented this week at the American Academy of Neurology’s (AAN) 59th Annual Meeting, demonstrating early efficacy, long-term tolerability, and high patient satisfaction with treatment in patients with relapsing forms of multiple sclerosis (MS).